Login / Signup
A concern about survival time as an endpoint in coronavirus disease 2019 clinical trials.
Kay See Tan
Published in:
Clinical trials (London, England) (2020)
Keyphrases
</>
coronavirus disease
clinical trial
respiratory syndrome coronavirus
free survival
phase ii
double blind
study protocol
sars cov